The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.
I4ID2022 will build on the successes of the previous editions, the first one starting in 2017, that counted with the presence of more than 1000 participants from different countries representing over 390 organizations and 180 internationally renowned speakers exchanging on immunotherapy and new therapeutic approaches to fight infectious diseases.
For this year edition I4ID202, the congress will address the thematic of Emerging diseases and antimicrobial-resistance
The I4ID2022 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.
Moreover, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering, through an online B2B platform.
Looking forward to welcoming you in November, 2022 in Lyon.
Best regards,
The Organizing Committee – Lyonbiopole and MabDesign
The Scientific Committee
